These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35297507)

  • 1. Pharmacy switching in response to preferred pharmacy networks in Medicare Part D.
    Xu J; Trish E; Joyce G
    Health Serv Res; 2022 Oct; 57(5):1112-1120. PubMed ID: 35297507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Part D beneficiaries' incentives and responses under preferred pharmacy networks.
    Xu J; Trish E; Joyce G
    Am J Manag Care; 2023 Apr; 29(4):180-186. PubMed ID: 37104832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
    DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
    JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with choice of pharmacy setting among DoD health care beneficiaries aged 65 years or older.
    Linton A; Garber M; Fagan NK; Peterson M
    J Manag Care Pharm; 2007 Oct; 13(8):677-86. PubMed ID: 17970605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pharmacists or pharmacies as Medicare Part D information sources.
    Kennelty KA; Thorpe JM; Chewning B; Mott DA
    J Am Pharm Assoc (2003); 2012; 52(6):e205-9. PubMed ID: 23229982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV
    J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
    J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of an open enrollment service on costs for Medicare Part D beneficiaries.
    Leonard CE; Cohenour FV; DeLoach LA; Galdo JA
    J Am Pharm Assoc (2003); 2017; 57(3S):S225-S228. PubMed ID: 28412055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
    Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
    J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ; Talbert JC; Brown J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.
    Kuye IO; Frank RG; McWilliams JM
    JAMA Intern Med; 2013 Jun; 173(12):1100-7. PubMed ID: 23649604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018.
    Li M; Bounthavong M
    J Manag Care Spec Pharm; 2021 Dec; 27(12):1750-1756. PubMed ID: 34818087
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the claim percent gross margin earned by Texas community independent pharmacies for dual-eligible beneficiary claims before and after Medicare Part D.
    Winegar AL; Shepherd MD; Lawson KA; Richards KM
    J Am Pharm Assoc (2003); 2009; 49(5):617-22. PubMed ID: 19748868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.